Jiangsu Gdk Biological Technology Co., Ltd

¥12.85As of Sun 8 Nov 2026, 12:00 UTC
SSE:688670Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (25.80%)
Div yield —
ROE (16.48%)
Biotechnology
Beta (5Y) 0.47
PE TTM —
TSR TTM (25.72%)
Mkt cap ¥1.583B
ROIC (18.17%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥13
0.59%
(26.66%)
Hold 7|12|3|8|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.16
0.18
0.17
0.18
15.70%
23.25%
13.29%
16.69%
Revenue¥M
144.8
144.9
149.2
157.2
10.71%
5.12%
7.75%
13.21%
Peers (US$237.3M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
3.890
0.128
0.129
EBIT/Intx
0.120
0.122
0.118
Own earn%
257.62
(105.01)
(98.16)
Sh yield%
28.83
28.47
31.83
Owners
Insiders/Inst%
8.24
57.19
Short interest%
5.84
SBC / revenue%
3.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
14–26
$1 testx
0.2
Incr. ROIC%
5